A simple, precise, and accurate method is developed and validated for the analysis of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol in tablet formulations. The method has shown adequate separation of the four ingredients from each other. Separation was achieved on a silica column (5 lm, 125 · 4.6 mm inner diameter) using a mobile phase consisting of methanol/ammonium dihydrogen phosphate buffer (90:10, v/v) at a flow rate of 1.0 ml/min and UV detection at 220 nm. This new method is validated in accordance with USP requirements for new methods for assay determination, which include accuracy, precision, selectivity, linearity and range, robustness and ruggedness. The current method demonstrates good linearity over the range of 0.15-0.45 mg/ml of pseudophedrine hydrochloride with r 2 of 0.996, and in the range of 0.075-0.225 mg/ml of dextromethorphan hydrobromide with r 2 of 0.992, and in the range of 0.01-0.03 mg/ml of chlorpheniramine maleate with r 2 of 0.994, and in the range of 0.25-0.75 mg/ml of paracetamol with r 2 of 0.991. The average recovery of the method is 99.7%, 98.6%, 98.1%, and 99.2% for pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol, respectively. The degree of reproducibility of the results obtained as a result of small deliberate variations in the method parameters and by changing analytical operator has proven that the method is robust and rugged.
Introduction
A combination of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol is used in pharmaceutical preparations for reducing symptoms which are usually associated with the common cold. Paracetamol has analgesic and antipyretic effects, pseudophedrine acts a decongestant, dextromethorphan is used as an antitussive agent, and chlorpheniramine is used as an antihistamine. Chemical structures of these four compounds are shown in Fig. 1 . In this respect, an analytical method is needed for the determination of this combination. In the USP (United States Pharmacopeia 32, 2009 ), there are two methods for determination of this combination; one is for the analysis of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and another for analysis of paracetamol. In the method for pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, an ion-pairing reagent (sodium lauryl sulfate) is employed, and evidences shows that the use of ion pairing agent alters the chemistry of the column, rendering it useless for separation except for ion-pair analysis (Milenkova et al., 2003) . Also, the method for pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate is not simultaneous i.e. for each analyte, different standard and sample preparations are needed. Many analytical methods are also described in the scientific literature for analysis of this combination. In 1984, Das Gupta and Heble (1984) have developed an HPLC method for the quantitation of paracetamol, chlorpheniramine maleate, dextromethorphan hydrobromide, and phenylpropanolamine hydrochloride in different pharmaceutical dosage forms using a single column and three different mobile phases (Das Gupta and Heble, 1984) . In 1987, Biemer has described a simultaneous analysis of paracetamol, pseudophedrine hydrochloride, and chlorpheniramine maleate in tablet formulations using an isocratic mixed micellar mobile phase (Biemer, 1987) . In 1996, De Orsi et al. have developed an LC method for the determination of paracetamol, pseudophedrine hydrochloride, dextromethorphan hydrobromide, and triprolidine in different pharmaceutical dosage forms using a reversed-phase C18 column and gradient elution and using two different wavelengths (De Orsi et al., 1996) . In 2001, Patil et al. have developed and validated an HPLC method for simultaneous determination of paracetamol, pseudophedrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin in bulk and pharmaceutical dosage forms using the technique of packed column supercritical fluid chromatography and a hypersil phenyl column with a ternary mobile phase (Patil et al., 2001) . Chen et al. have also described in 2001 an HPLC method for the simultaneous determination of chlorpheniramine maleate, paracetamol, and pseudophedrine hydrochloride in tablet for-mulations (Chen et al., 2001) . In 2003, Milenkova et al. have developed an HPLC method for simultaneous determination of paracetamol, pseudophedrine hydrochloride, and dextromethorphan hydrobromide in tablet preparations (Milenkova et al., 2003) . In 2006, Murtha et al. have developed a method for simultaneous determination of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate in tablet preparations by second-derivative photodiode array spectroscopy (Murtha et al., 2006) .
The aim of the current work is to develop a simple and simultaneous HPLC method for the determination of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol without using ion-pairing agent in the mobile phase. Validation of the current method was conducted for these ingredients which include accuracy, precision, selectivity, linearity and range, robustness and ruggedness.
Experimental

Chemicals
Methanol HPLC grade is from J.T Baker (NJ, USA). Methanol AR and ammonium dihydrogen phosphate are from Merck (Darmstadt, Germany). Pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol are from USP (Rockville, MD, USA).
Apparatus
LC system (Dionex System, USA) with a detector (PDA-3000, 08011275), equipped with a pump (LPG-3400A, 8007455), autosampler (WPS-300SL analytical 8008961), column compartment (TCC-3000, 8008864), and solvent rack (SR-3000) was employed during this study. The Chromeleon software was employed. The chromatographic analysis was performed on a Nova-pak silica column (4 lm), (15.0 cm length, 3.9 mm inner diameter) (Waters Corporation, Milford, Massachusetts, USA).
Standard solutions and HPLC conditions
Phosphate buffer was prepared by dissolving 1.15 g of ammonium dihydrogen phosphate in 1000 ml of water. A filtered and degassed mixture of methanol and buffer (90:10, v/v) was employed as a mobile phase at a flow rate of 1.0 ml/min and a detection wavelength of 220 nm.
Stock standard solution was prepared by dissolving 500 mg of paracetamol, 150 mg of dextromethorphan hydrobromide, 300 mg of pseudophedrine hydrochloride, and 20 mg of chlorpheniramine maleate in 100.0 ml of methanol. Nominal standard solution was prepared by diluting 5 ml of stock standard solution to 50 ml with mobile phase to obtain a solution having a known concentration of 0.50 mg/ml of paracetamol, 0.15 mg/ml of dextromethorphan hydrobromide, 0.30 mg/ml of pseudophedrine hydrochloride, and 0.02 mg/ml of chlorpheniramine maleate.
Nominal solutions of the formulated tablets were prepared by dissolving a quantity of the powdered tablet equivalent to 30.0 mg of pseudophedrine hydrochloride in 100.0 ml of mobile phase to get the same concentration as in the standard solution. Figure 1 Structure of dextromethorphan, chlorphenamine, pseudoephedrine, and paracetamol.
Results and discussion
Method development
Preliminary studies involved trying phenyl and silica columns and testing several mobile phase compositions for the effective separation of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol. Silica column (4 lm, 15.0 cm length, 3.9 mm inner diameter) eluted with a mobile phase of methanol/ammonium dihydrogen phosphate buffer (90:10, v/v) at a flow rate of 1.0 ml/min and a detection wavelength of 220 nm afforded the best separation of these analytes, see Fig. 2 and Table 1 .
Method validation
After method development, the validation of the current method has been performed in accordance with USP requirements for assay determination (Category-I: analytical methods for quantitation of active ingredients in finished pharmaceutical products) which include accuracy, precision, selectivity, linearity and range, robustness and ruggedness.
Linearity and range
To evaluate linearity of the method, different concentrations of the four analytes in the range of 0.25-0.75 mg/ml for paracetamol, 0.15-0.45 mg/ml for pseudophedrine hydrochloride, 0.075-0.225 mg/ml for dextromethorphan hydrobromide, and 0.01-0.03 mg/ml for chlorpheniramine maleate were analyzed and the linearity between the peak-area and the concentration was examined for each analyte. The results obtained show that the current method is linear for the three analytes in the range specified above with a correlation coefficient of better than 0.99.
Accuracy (recovery)
Accuracy of the method was studied by preparing the placebo of the drug tablet formulation according to the formulation procedure. To the required quantity of placebo, a known quantity of the four active ingredients (paracetamol, pseudophedrine hydrochloride, dextromethorphan hydrobromide, and chlorpheniramine maleate) with the same proportion as in the drug formulation was added to get simulated drug formulation. Results have shown that the mean recovery of the assay is within 100 ± 2.0% for each ingredient, and the RSD is lower than 1.0%, see Table 2 .
Precision
The precision of this method was evaluated by calculating the RSD of the peak areas of six replicate injections of the nominal standard solution, which was found to be 0.57%, 0.30%, 0.82%, and 0.72% for pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol, respectively. Furthermore, the RSD of three replicates of the recovery data analyzed in accuracy study was calculated, and it was found to be less than 1.0%, see Table 2 . These results show that the current method is repeatable.
Selectivity
Selectivity of the current method was demonstrated by good separation of the four analytes from each other, see Fig. 2 . Furthermore, excipient of the tablet formulation did not interfere with the active ingredients of the drug product, see Fig. 2 .
Robustness and ruggedness
Robustness of an analytical method is a measure of its capacity to remain unaffected by small but deliberate variations in method parameters, and provides an indication of its reliability during normal usage. Robustness of the current method was investigated by analyzing samples of the drug product using the same chromatographic conditions set forth in method development but with a small change in the following chromatographic parameters: (a) flow rate: 1.3 and 1.7 ml/min instead of 1.5 ml/min, (b) detection wavelength: 215 and 225 nm instead of 220 nm, and (c) volume fraction of methanol: 83% and 87% instead of 85%. RSD of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol assay under these conditions is calculated to be less than 1%, see Table 3 . Ruggedness of the current method was demonstrated by analyzing six samples (assay) of tablet formulation by two analysts in the same laboratory. The RSD for the 12 samples is calculated to be 0.55%, 0.62%, and 0.49% for pseudophedrine hydrochloride, dextromethorphan hydrobromide, and chlorpheniramine maleate, respectively, indicating the ruggedness of the method.
Conclusions
A simple, accurate, precise LC method is developed and validated for simultaneous determination of pseudophedrine hydrochloride, dextromethorphan hydrobromide, chlorpheniramine maleate, and paracetamol in tablet formulation. 
